Viewing nowJW Pioglitazone 15 mg Tablet (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

MFDS item code 202002025 · Approved 2020.03.23
Improvement and therapeutic effect of blood sugar control in type 2 diabetes.
This medicine is used as an adjunct to dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be administered as monotherapy and can be combined with sulfonylureas, metformin, or insulin if there is no effect from other oral hypoglycemics. Additionally, nutritional counseling, weight loss, and consistent exercise therapy are important for patients, which are essential not only for initial treatment but also for maintaining the effectiveness of drug therapy. This medicine helps to improve blood sugar control.
This medicine is to be taken orally once daily, irrespective of meals. As monotherapy, it can start at 15 mg once daily, and may be increased to a maximum of 30 mg once daily if necessary. In combination therapy, the dosing remains 15 mg once daily, with a maximum recommended dose of 30 mg once daily.
There is no experience in using this medicine for children under 18 years of age, so administration is not recommended.
This medicine is used for the treatment of type 2 diabetes and helps regulate blood sugar by improving insulin resistance. This medicine may worsen or induce a condition called congestive heart failure, so it should not be administered to patients with heart failure or a history of heart failure. During treatment, symptoms such as weight gain, edema, and dyspnea may occur, and if these symptoms arise, healthcare professionals should be informed immediately. Patients with active bladder cancer or a history of bladder cancer should not use this medicine, and if hematuria or urinary disturbances develop or worsen, the possibility of bladder cancer should be considered and the physician should be notified. Patients with impaired liver function should also use this medicine cautiously and undergo regular liver function tests before and during treatment. The risk of hypoglycemia may increase when this medicine is used in conjunction with insulin, so patients should be well-informed about the symptoms of hypoglycemia and how to respond, and insulin dosage adjustments may be necessary if needed. This medicine can cause edema and weight gain, so patients with existing edema or at risk of heart disease should exercise extra caution. Pre-menopausal women may experience enhanced ovulation leading to increased chances of pregnancy when using this medicine, thus appropriate contraceptive methods should be employed. Elderly patients or those with impaired kidney and liver function may have a higher risk of side effects when taking this medicine, so it should be used carefully under the guidance of healthcare professionals. It is advisable for women who are pregnant or may become pregnant to avoid using this medicine, and those who are breastfeeding should consult their physician before use. This medicine may interact with other medications, so patients must inform their healthcare provider about any other medications they are taking. Regular blood glucose and liver function tests should be conducted during treatment, and patients should closely observe any changes in weight, edema, or dyspnea. It is important to consult a physician immediately if any unusual symptoms arise during medication use to receive appropriate care.
Congestive heart failure, symptoms and signs of heart failure (excessive weight change, dyspnea, severe edema), severe heart failure, cardiac failure, myocardial infarction, stroke, severe edema, urinary disturbances, severe skin adverse reactions (severe rash, blistering, skin peeling, mucosal pain), severe allergic reactions (urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor), liver abnormalities (including jaundice), fatal and
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a container that can block light and air, and should be kept away from humid areas. The storage temperature should be between 15 degrees to 30 degrees, ideally around 25 degrees.
This medicine is a white round tablet.
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.